Fuzhou General Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma

Conditions: Glioblastoma

Interventions: Drug: Apatinib
Drug: Temozolomide（TMZ）

First Posted Date: 2018-06-25

Last Posted Date: 2020-03-03

Lead Sponsor: Fuzhou General Hospital

Target Recruit Count: 60

Registration Number: NCT03567135

Locations: 🇨🇳
Fuzhou General Hospital, Fuzhou, Fujian, China

The Plasma Diafiltration Therapy of Hepatic Failure

Not Applicable

Conditions: Hepatic Failure
Plasma Exchange

Interventions: Procedure: conventional PDF treatment group
Procedure: simple plasma exchange
Procedure: less plasma PDF treatment group

First Posted Date: 2018-06-18

Last Posted Date: 2018-06-18

Lead Sponsor: Fuzhou General Hospital

Target Recruit Count: 60

Registration Number: NCT03560414

Locations: 🇨🇳
Fuzhou General Hospital, Xiamen Univ, Fuzhou, Fujian, China

Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis

Phase 1

Conditions: Primary Sclerosing Cholangitis

Interventions: Drug: UCMSC
Drug: UDCA

First Posted Date: 2018-05-04

Last Posted Date: 2018-05-04

Lead Sponsor: Fuzhou General Hospital

Target Recruit Count: 20

Registration Number: NCT03516006

Mesenchymal Stem Cells in Central Nervous System injury2017

Phase 1

Conditions: Central Nervous System Injury

Interventions: Drug: UCMSCC
Drug: conventional treatment

First Posted Date: 2017-09-25

Last Posted Date: 2017-09-25

Lead Sponsor: Fuzhou General Hospital

Target Recruit Count: 30

Registration Number: NCT03291366

Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC

Phase 2

Terminated

Conditions: Nonsmall Cell Lung Cancer

Interventions: Drug: Apatinib/docetaxel/pemetrexed
Drug: docetaxel/pemetrexed

First Posted Date: 2017-08-22

Last Posted Date: 2021-02-08

Lead Sponsor: Fuzhou General Hospital

Target Recruit Count: 37

Registration Number: NCT03256721

Locations: 🇨🇳
Fuzhou general hospital, Fuzhou, Fujian, China

Clinical Study of Microchimerism and cfDNA as Biomarkers for Acute Rejection After Organ Transplantation

Conditions: Organ Transplant Rejection

Interventions: Other: no interventions

First Posted Date: 2017-08-21

Last Posted Date: 2017-08-21

Lead Sponsor: Fuzhou General Hospital

Target Recruit Count: 950

Registration Number: NCT03255265

Locations: 🇨🇳
Fuzhou General Hospital, Xiamen Univ Fuzhou, Fujian China, Fuzhou, Fujian, China

Induction With SVF Derived MSC in Living-related Kidney Transplantation

Phase 1

Conditions: Living-relative Kidney Transplantation

Interventions: Procedure: SVF-MSC induction
Drug: Basiliximab induction

First Posted Date: 2015-07-08

Last Posted Date: 2015-07-08

Lead Sponsor: Fuzhou General Hospital

Target Recruit Count: 120

Registration Number: NCT02492308

Locations: 🇨🇳
Xi er huan road No.156, Fuzhou, Fujian, China

Effect of SVF Derived MSC in DCD Renal Transplantation

Phase 1

Conditions: Uremia

Interventions: Other: SVFderived MSC transplantations
Drug: Basiliximab

First Posted Date: 2015-07-08

Last Posted Date: 2015-07-08

Lead Sponsor: Fuzhou General Hospital

Target Recruit Count: 120

Registration Number: NCT02492490

Locations: 🇨🇳
Fuzhou General Hospital, Xiamen Univ, Fuzhou, Fujian, China

Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease

Phase 1

Completed

Conditions: Crohn Disease

Interventions: Other: UC-MSCs by peripheral intravenous infusion
Drug: received hormone maintenance therapy

First Posted Date: 2015-05-15

Last Posted Date: 2017-01-18

Lead Sponsor: Fuzhou General Hospital

Target Recruit Count: 82

Registration Number: NCT02445547

Locations: 🇨🇳
Shaanxi Provincial People's Hospital, Xi Ail, Shaanxi, China

Islet Transplantation Through an Indwelling Catheter in the Umbilical Vein

Phase 1

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Procedure: umbilical vein catheterization

First Posted Date: 2015-02-20

Last Posted Date: 2015-02-20

Lead Sponsor: Fuzhou General Hospital

Target Recruit Count: 12

Registration Number: NCT02367534

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy